Earlier this week, the United States Food and Drug Administration (FDA) approved a human trial for a blueberry-sized brain ...
In April 2026, COMPASS Pathways announced that the FDA granted a rolling NDA review for its synthetic psilocybin therapy ...
The newly approved device aims to treat depression by directly stimulating neural activity.
Gadget Review on MSN
FDA just cleared the first wireless brain implant for severe depression
Brain implant gets FDA clearance for first wireless depression treatment trial, offering battery-free stimulation in ...
The federal government is opening the door for more research on psychedelics—and potential future approval—as a form of ...
A device the size of a blueberry is hypothesized to give people with treatment-resistant depression another option — and the FDA is giving its Houston maker a chance to test it.
FDA approved a request from Motif Neurotech, to start an initial feasibility trial to test a brain implant to treat ...
The first drug for women suffering postpartum depression received federal approval on Tuesday, a move likely to pave the way for a wave of treatments to address a debilitating condition that is the ...
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson‘s Caplyta as an add-on treatment for adults with major depressive disorder. Following the FDA’s Nov. 5 decision ...
Diabetes and weight loss drugs, like Olympic, may also be linked to mental health. According to a new study results, people ...
SAN FRANCISCO, California -- For the first time, the FDA has approved a medication specifically to treat new mothers who suffer from postpartum depression. The drug is called Brexanolone and will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results